Driving Innovation: Navigating IP Complexity in a Rapidly Evolving Landscape

Innovation across life sciences continues to accelerate, while the environments for protecting and commercialising that innovation are becoming increasingly complex. Crowded patent landscapes, evolving legal standards, rising development costs, and heightened regulatory scrutiny are forcing IP teams to rethink how they manage, defend, and extract value from their portfolios.

On June 10th 2026, join 70+ senior IP leaders from across the pharma and biotech to discuss how to ensure an adaptable and future-proof IP strategy.

Speakers include:

What to expect:

“The whole process is very valuable and efficient. The roundtable discussions are as engaging and informative as any I've attended at other conferences, without the lost time and energy associated with travel. The service provider meetings are targeted and effective.” - Director of Intellectual Property, Immunobiology Company

“Overall it was a positive experience. It was my first time at the IP Collective and I had a great conversation with the panel and my peers.” - Senior Corporate Counsel, Fortune 500 Company

“Just wanted to say thanks for setting up these meetings and making the matches. I actually enjoyed each of the conversations. They were efficient, each was different and there are 3 new potential service providers (which I may recommend outside, to other colleagues in the industry too.” - Director of IP & Licensing, Biotech Company